SEC CIK 1673852
Novartis Institutes for BioMedical Research, Inc.
Reported ownership across 1 company, sourced from SEC Form 4 filings and updated daily.
Current Positions
| Company | Shares Owned | As Of |
|---|---|---|
| NTLAview stock → | 4,277,073 | 2018-03-16 |
Position History — NTLA
Reported shares owned immediately after each Form 4 transaction, over time.
Recent Filings — NTLA
| Date | Activity | Shares | Price | Owned After |
|---|---|---|---|---|
| 2018-03-16 | — | — | — | 4,277,073 |
| 2017-12-12 | Open-market sale | 1,523,000 | $18.30 | 4,129,903 |
| 2017-03-03 | J | 79,245 | $0.00 | 5,652,903 |
| 2016-05-11 | Conversion (derivative) | 4,761,905 | $0.00 | 0 |
| 2016-05-11 | Conversion (derivative) | 761,905 | $0.00 | 0 |
| 2016-05-11 | Conversion (derivative) | 2,666,666 | $0.00 | 0 |
| 2016-05-11 | Conversion | 1,724,240 | — | 4,803,241 |
| 2016-05-11 | Conversion | 492,640 | — | 5,295,881 |
| 2016-05-11 | Open-market buy | 277,777 | $18.00 | 5,573,658 |
| 2016-05-11 | Conversion | 3,079,001 | — | 3,079,001 |
Source: SEC EDGAR Form 4 filings. For informational purposes only — not investment advice.